Company Sino Biological,Inc.

Equities

301047

CNE100004Q23

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Sino Biological,Inc.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
70.51 ^CNY	-0.14%		+2.62%	-14.43%

04-28	Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-26	Sino Biological,Inc. completed the acquisition of SignalChem Biotech Inc. from Signalchem Lifesciences Corporation.	CI

Sino Biological Inc is a China-based biotechnology company engaged in the research and development, production, sales and technical services of biological reagents. The Company's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The Company operates in the domestic market and overseas markets.

Number of employees: 953

CNY in Million	2022	Weight	2023	Weight	Delta
Recombinant Protein 39.5 %	261	45.4 %	256	39.5 %	-2.02%
Antibody 28.0 %	166	28.9 %	181	28.0 %	+8.99%
Contract Research Organization Services 23.8 %	110	19.1 %	154	23.8 %	+40.49%
Culture Medium 4.3 %	27	4.7 %	28	4.3 %	+2.76%
Realtor 2.4 %	-	-	15	2.4 %	-
Gene 1.8 %	11	1.9 %	12	1.8 %	+6.67%
Other 0.1 %	-	-	1	0.1 %	-

CNY in Million	2022	Weight	2023	Weight	Delta
Overseas 62.1 %	350	60.8 %	401	62.1 %	+14.73%
China 37.9 %	225	39.2 %	245	37.9 %	+9.02%

Managers	Title	Age	Since
Jie Zhang CEO	Chief Executive Officer	51	16-12-31
Jing Wang CHM	Chairman	39	16-12-31
Tao Feng DFI	Director of Finance/CFO	43	17-03-31
Liang Zhi Xie CHM	Chairman	58	16-12-21
Yan Zhang IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Yong You BRD	Director/Board Member	51	23-04-11
Shi Zhou Yin BRD	Director/Board Member	51	20-03-25
Liang Zhi Xie CHM	Chairman	58	16-12-21
Yan Min Tang BRD	Director/Board Member	51	18-03-31
Jie Zhang CEO	Chief Executive Officer	51	16-12-31
Xiao Fang Chen BRD	Director/Board Member	56	20-02-29
Chang Yuan Yu BRD	Director/Board Member	62	20-03-25
Jing Wang CHM	Chairman	39	16-12-31
Ran Gao BRD	Director/Board Member	38	17-06-30
Xiao Tong Wang BRD	Director/Board Member	35	16-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	129,200,000	37,882,749 ( 29.32 %)	0	29.32 %

Name	Equities	%	Valuation
Qiming Venture Partners Ltd. 19.70 %	11,519,472	19.70 %	113 M ¥
Zhejiang Qingsong Investment Management Co., Ltd. 5.668 %	3,313,509	5.668 %	32 M ¥
Tianjin Yiqiao Anyuan Enterprise Management Consultancy LP 5.338 %	3,120,608	5.338 %	31 M ¥
Tianjin Yiqiao Antai Enterprise Management Consultancy LP 3.538 %	2,068,396	3.538 %	20 M ¥
Hwabao WP Fund Management Co., Ltd. 3.160 %	1,847,309	3.160 %	18 M ¥
Tianjin Yiqiao Anheng Enterprise Management Consultancy LP 1.969 %	1,151,070	1.969 %	11 M ¥
GF Fund Management Co., Ltd. 0.2976 %	174,000	0.2976 %	2 M ¥
Guotai Asset Management Co., Ltd. 0.2650 %	154,955	0.2650 %	2 M ¥
China Asset Management Co., Ltd. 0.2085 %	121,923	0.2085 %	1 M ¥
China Southern Asset Management Co., Ltd. 0.1629 %	95,217	0.1629 %	932 745 ¥

Name	Equities	%	Valuation
Liang Zhi Xie 95.96 %	67,881,551	95.96 %	665 M ¥
Tianjin Yiqiao Anyuan Enterprise Management Consultancy LP 2.438 %	1,724,392	2.438 %	17 M ¥
Tianjin Yiqiao Anheng Enterprise Management Consultancy LP 0.4275 %	302,430	0.4275 %	3 M ¥
Tianjin Yiqiao Antai Enterprise Management Consultancy LP 0.3334 %	235,823	0.3334 %	2 M ¥

Sino Biological Inc.

Room 306, Bldg 9, Courtyard 18 Kechuang 10th Street

100176, Beijing

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

70.51 CNY

Average target price

102.5 CNY

Spread / Average Target

+45.37%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
SINO BIOLOGICAL,INC.	-14.43%	1.24B
MODERNA, INC.	+19.53%	42.68B
IQVIA HOLDINGS INC.	-1.96%	42.4B
LONZA GROUP AG	+45.21%	40.04B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.57%	24.94B
ALNYLAM PHARMACEUTICALS, INC.	-21.15%	18.96B
MEDPACE HOLDINGS, INC.	+30.32%	12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.58%	11.95B
BIO-TECHNE CORPORATION	-3.47%	11.55B

Other Biotechnology & Medical Research